Key somatic mutations in PCa include fusions of TMPRSS2 with ETS family genes, amplification of the MYC oncogene, deletion and/or mutation of PTEN, RB1, and TP53 in advanced disease, together with amplification and/or mutation of the androgen receptor (AR) [9]. Here, TMPRSS2 is linked to posterior cortical atrophy.